Colorectal metastases confined to the liver: a unique opportunity? Read more about Colorectal metastases confined to the liver: a unique opportunity?
Complementary and alternative therapies in prostate cancer. Read more about Complementary and alternative therapies in prostate cancer.
Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response. Read more about Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response.
Molecular mechanisms underlying the development of hepatocellular carcinoma. Read more about Molecular mechanisms underlying the development of hepatocellular carcinoma.
Temozolomide in combination with other cytotoxic agents. Read more about Temozolomide in combination with other cytotoxic agents.
Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer. Read more about Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.
Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer. Read more about Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.
Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Read more about Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women.
Future directions in the treatment of malignant gliomas with temozolomide. Read more about Future directions in the treatment of malignant gliomas with temozolomide.
Biology and treatment of malignant glioma. Read more about Biology and treatment of malignant glioma.
